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1 Sequential analysis is a tool for quantifying the amount of information, 2 and it can therefore determine when firm evidence is reached in cumulative meta-analysis.
We recently carried out a sequence analysis in which we examined the data from nine "secure" trials (10 529 patients) of perioperative β blockade.
3 Our analysis showed that the optimal sample size to show a relative difference of ±25% in the endpoint of mortality would be 17 495 patients, but that these nine secure trials demonstrate at least futility (proof of no effectiveness).
This result is more informative than demonstration of inconclusiveness (no proof of effectiveness).
4 5 The analysis was also close to demonstrating inferiority-the boundary of inferiority in the sequential analysis graph was approached but not crossed.
Hence, on the basis of our analysis, the use of β blockade in non-cardiac surgery was statistically proved to be ineffective (futility) and there was also a trend towards a harmful effect.
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